---
title: "AbbVie Inc. Stock Underperforms Monday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291841855.md"
description: "AbbVie Inc. (ABBV) shares fell 2.42% to $254.76 on Monday, underperforming the broader market as the S&P 500 and Dow Jones rose. The stock closed 2.63% below its 52-week high of $261.64. Trading volume was below the 50-day average. Compared to competitors, AbbVie's decline was mixed against Johnson & Johnson, Pfizer, and Amgen, which also saw declines."
datetime: "2026-07-06T20:31:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291841855.md)
  - [en](https://longbridge.com/en/news/291841855.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291841855.md)
---

# AbbVie Inc. Stock Underperforms Monday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of AbbVie Inc. (ABBV) slid 2.42% to $254.76 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.72% to 7,537.43 and the Dow Jones Industrial Average rising 0.29% to 53,055.91.

AbbVie Inc. closed 2.63% below its 52-week high of $261.64, which the company achieved on July 2nd.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) fell 1.41% to $259.33, Pfizer Inc. (PFE) fell 2.47% to $23.72, and Amgen Inc. (AMGN) fell 2.06% to $366.44.

Trading volume (6.9 M) remained 419,543 below its 50-day average volume of 7.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 6, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-06-26 1631ET

### Related Stocks

- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)

## Related News & Research

- [AbbVie (ABBV) Stock May Be 45% Below Fair Value As Rinvoq Expands In Europe](https://longbridge.com/en/news/295294852.md)
- [AbbVie (ABBV) Lifted Guidance, Has The Market Already Priced It In?](https://longbridge.com/en/news/294844923.md)
- [Central Pacific Bank Trust Division Sells 4,628 Shares of AbbVie Inc. $ABBV](https://longbridge.com/en/news/294933097.md)
- [AbbVie piles on $8 billion in debt for its Apogee deal -- should dividend investors worry?](https://longbridge.com/en/news/295533701.md)
- [AbbVie Inc Stock (ABBV) Moved Up by 3.35% on Jul 28: A Full Analysis](https://longbridge.com/en/news/294086753.md)